Genetic and molecular genetic studies in the diagnosis of B-cell lymphomas: Marginal zone lymphomas

Human Pathology

Volumn 34, Issue 4, 2003, Pages 336-340

  Muller Hermelink H K ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD20 ANTIGEN; CD23 ANTIGEN; CD5 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; CYCLIN D1; IMMUNOGLOBULIN HEAVY CHAIN; PROTEIN BCL 2; PROTEIN BCL 6; PROTEIN P53;

B CELL LYMPHOMA; CHROMOSOME TRANSLOCATION; CLINICAL FEATURE; CLONAL VARIATION; CONFERENCE PAPER; CYTOGENETICS; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; EXTRANODAL MARGINAL ZONE B CELL LYMPHOMA; FLUORESCENCE IN SITU HYBRIDIZATION; FOLLICULAR LYMPHOMA; GENE EXPRESSION; HUMAN; IMMUNOPHENOTYPING; KARYOTYPING; LARGE CELL LYMPHOMA; MARGINAL ZONE B CELL LYMPHOMA; MOLECULAR GENETICS; PATHOGENESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0038415959     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1053/hupa.2003.98     Document Type: Conference Paper

References (26)

1. Isaacson P, Wright DH: Extranodal malignant lymphoma arising from mucosa-associated lymphoid tissue. Cancer 53:2515-2524, 1984
2. Harris NL, Jaffe ES, Stein H, et al: A revised European- American assification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group. Blood 84:1361-1392, 1994
3. Harris NL, Jaffe ES, Diebold J, et al: Lymphoma classification - From controversy to consensus: The REAL and WHO classification of lymphoid neoplasms. Ann Oncol 11 (suppl 1):3-10, 2000
4. Dunn-Walters DK, Boursier L, Spencer J, et al: Analysis of immunoglobulin genes in splenic marginal zone lymphoma suggests ongoing mutation. HUM PATHOL 29:585-593, 1998
5. Ott G, Katzenberger T, Greiner A, et al: The t(11;18) (q21; q21) chromosome translocation is a frequent and specific aberration in low-grade but not high-grade malignant non-Hodgkin's lymphomas of the mucosa-associated lymphoid tissue (MALT-) type. Cancer Res 57:3944-3948, 1997
6. Dierlamm J, Baens M, Wlodarska I, et al: The apoptosis inhibitor gene API2 and a novel 18q gene, MLT, are recurrently rearranged in the t(11; 18) (q21;q21) p6 associated with mucosa-associated lymphoid tissue lymphomas. Blood 93:3601-3609, 1999
7. Yoneda T, Imaizumi K, Maeda M, et al: (2000). "Regulatory mechanisms of TRAF2-mediated signal transduction by Bcl10, a MALT lymphoma-associated protein." J Biol Chem 275:11114-11120, 2000
8. McAllister-Lucas LM, Inohara N, Lucac PC, et al: Bimpl, a MAGUK family member linking PKC activation to Bcl10-mediated NF-kB induction. J Biol Chem 276:30589-30597, 2001
9. Rosenwald A, Ott G, Stilgenbauer S, et al: Exclusive detection of the t(11;18) (q21;q21) in extranodal marginal zone B cell lymphomas (MZBL) of MALT type in contrast to other MZBL and extranodal large B cell lymphomas. Am J Pathol 155:1817-1821, 1999
10. Paternoster SF, Brockman SR, McCure RF, et al: A new method to extract nuclei from paraffin-embedded tissue to study lymphomas using interphase fluorescence in situ hybridization. Am J Pathol 160:1967-1972, 2002
11. Remstein ED, James CD, Kurtin PJ: Incidence and subtype specificity of AP/2-MALT1 fuson translocations in extranodular, nodal, and splenic marginal zone lymphomas. Am J Pathol 156:1183-1188, 2000
12. Motegi M, Yonezumi M, Suzuki H, et al: API2-MALT1 chimeric transcripts involved in mucosa-associated lymphoid tissue type lymphoma predict heterogeneous products. Am J Pathol 156:807-812, 2000
13. Starostik P, Patzner J, Greiner A, et al: Gastric marginal zone B-cell lymphomas of MALT type develop along 2 distinct pathogenetic pathways. Blood 99:3-9, 2002
14. Fischbach W, Goebeler-Kolve M, Starostik P, et al: Minimal residual low-grade gastric MALT-lymphoma after eradication of Helicobacter pylori. Lancet 360:5477-5478, 2002
15. Maes B, Baens M, Marynen F, et al: The product of the t(11;18), an API2-MLT fusion, is an almost exclusive finding in marginal zone cell lymphoma of extranodal MALT-type. Ann Oncol 11:521-526, 2000
16. Barth TF, Bentz M, Leithauser F, et al: Molecular-cytogenetic comparison of mucosa-associated marginal zone B-cell lymphoma and large B-cell lymphoma arising in the gastro-intestinal tract. Genes Chromosomes Cancer 31:316-325, 2001
17. Du MQ, Peng H, Liu H, et al: BCL10 gene mutation in lymphoma. Blood 95:3885-3890, 2000
18. Ott MM, Ott G, Roblick U, et al: Localized gastric nonHodgkin's lymphoma of high-grade malignancy in patients with preexisting chronic lymphocytic leukemia or immunocytoma. Am J Pathol 157:1147-1154, 2000
19. Ye H, Dogan A, Karran L, et al: BCL10 expression in normal and neoplastic lymphoid tissue. Nuclear localization in MALT lymphoma." Am J Pathol 157:1147-1154, 2000
20. Seeberger H, Starostik P, Schwarz S, et al: Loss of Fas (CD95/APO-1) regulatory function is an important step in early MALT-type lymphoma development. Lab Invest 81:977-986, 2001
21. Ott G, Katzenberger T, Lohr A, et al: Cytomorphologic, immunohistochemical, and cytogenetic profiles of follicular lymphoma: types of follicular lymphoma grade 3. Blood 99:3806-3812, 2002
22. Finn LS, Viswanatha DS, Belasco JB, et al: Primary follicular lymphoma of the testis in childhood. Cancer 85:1626-1635, 1999
23. Atra A, Meller ST, Stevens S, et al: Conservative management of follicular non-Hodgkin's lymphoma in childhood. Br J Haematol 103:220-223, 1998
24. Wang J, Raffeld M, Medeiros LJ, et al: Follicular center cell lymphoma with the t(14;18) translocation in which the rearranged BCL-2 gene is silent. Leukemia 7:1834-1839, 1993
25. Skinnider PF, Horsman DE, Dupuis B, et al: Bcl-6 and BCL-2 protein expression in diffuse large B cell lymphoma and follicular lymphoma: correlation with 3q27 and 18q21 chromosomal abnormalities. HUM PATHOL 30:803-808, 1999
26. Alizadeh AA, Eisen MB, Davis RE, et al: Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403:503-511, 2000